Manufacturer record

Mfg By: Geenac Pharma: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Mfg By: Geenac Pharma (Uttarakhand) were declared Not of Standard Quality between January 2025 and January 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

1 record linked to Mfg By: Geenac Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jan 2025 to Jan 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2025
1
Products affected
Assay
Most common failure
Jan 2025
Latest alert

Flagged batches per year

2025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Cefpodoxim e & Potassium Clavulanate Tablets BPT- 3003Mfg ? · Exp ? NOT OF STANDARD QUALITY The sample does not meets the Specifications wrt. Identification test - and Assay - for Cefpodoxime and Clavulanic Acid as per STP. U/S. 17 B of Drugs and Cosmetics Act 1940. The Sample is deemed to be Spurious Drug.Assay State Lab Drugs Control Laboratory, TelanganaState lab Jan 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.